Researchers have found significant variation both between and within HeLa cell lines
New technique enables creation of a full developmental lineage record for cells in vivo
Combined capabilities provide scientists with access to new and existing immortalized cell lines for use in broad research applications and clinical markets.
Haplogen, a biotechnology company developing antiviral therapies, and CeMM, the Center for Molecular Medicine of the Austrian Academy of Sciences, today announced that they are making available their large collection of human cell lines that are deficient for single genes, which they have been building over the past three years as part of a public-private partnership.
New NIH policy requires researchers to apply for access to the full genome sequence data from HeLa cells.
Cross-contamination of human cell lines with other cell lines and/or misidentification of cell cultures is reported to be 18-36 percent. Find out one way to prevent contamination in your lab.